Dad and Husband. Christian. Assistant Professor @radonc_ou. Fan of all things Disney.
Joined July 2013
- Tweets108
- Following633
- Followers334
- Likes1.4K
Timothy Malouff retweeted
I'm extremely excited to be joining this team next year -- hope you'll join us!
jobs.mayoclinic.org/job/roch…
@DanielMaMD @DavidRoutmanMD @TheColonelGray @JWilsonOkun @tmalouff @n_laack @MayoRadOnc
🔔🔔Pass it along!
We are hiring for a Head & Neck position!
jobs.mayoclinic.org/job/roch…
Timothy Malouff retweeted
Just a day away from #ASTRO24 & we have exciting news of our own!
We are hiring a #radonc for the "breast" team ever!
Send your CV to @dshumway ([email protected]) so we can chat at ASTRO!
& apply 👇
jobs.mayoclinic.org/job/roch…
@KimCorbinMD @tmalouff @MayElbannaMDPhD
Timothy Malouff retweeted
Exciting talk by All-Star @MayoRadOnc resident Daniel Ebner on stereotactic proton therapy and immunotherapy for recurrent H&N cancer at @PTCOGNA 9th Annual Meeting!
Timothy Malouff retweeted
Only managed to find about half of team @radonc_OU but we’ve got residents, therapy, med phys, and clinical faculty all repping strong this year! #ASTRO23 – at San Diego, CA
Timothy Malouff retweeted
Calling all rad oncs, educators, and more! Join us for our next @RadiologyACR Webinar:
Diversity, Equity, and Inclusion in Radiation Oncology
Aug. 16 | 5–6:30pm ET
Link to register: acr.org/Clinical-Resources/R…
Timothy Malouff retweeted
Great podcast that tells you everything you need to know about how to radiate recurrent/refractory lymphoma in the setting of transplant or CAR-T.
Direct link at: redjournal.org/pb-assets/Hea…
@belinda_campbe @MarioLevis82 @MayoCancerCare @ILROGTeam
Timothy Malouff retweeted
🚨@Haematologica: Consolidative RT (cRT) vs observation for residual disease/FDG-activity on day+30 post-CART?
cRT alters pattern of relapse➡️ improves local recurrence-free survival (2yr 100% vs 31%)➡️ improves progression-free survival (2yr 73% vs 37%)
doi.org/10.3324/haematol.202…
Timothy Malouff retweeted
Congratulations to our resident @AaronBushMD for being selected to be apart of Mayo Clinic GME's Clinician Educator Pathway from a very competitive pool. This is a huge achievement and look forward to seeing all the great things you will accomplish this year! #radonc @ARRO_org
Timothy Malouff retweeted
OU Health Stephenson Cancer Center Researcher Leads Global Study Investigating Immunotherapy Drugs for People Living With Cancer and HIV
ouhealth.com/blog/2023/may/o…
An awesome place to rotate and do residency! Highly recommend checking it out as a medical student.
A #radonc away rotation @MayoClinicFlorida means a month to explore the best of Jacksonville, FL: our campus, outstanding faculty, & what residency in sunshine state really feels like! 🌴☀️🌊
🚨 Apply soon via VSLO or email [email protected] #match2024🚨
Timothy Malouff retweeted
Financial Toxicity in #Cancer Care: Implications for Clinical Care and Potential Practice Solutions.
ascopubs.org/doi/abs/10.1200…
@ASCO @JCO_ASCO @JCOOP_ASCO @ShankaranVeena
#FinancialToxicity #PallOnc #CostsofCare @CostsofCare
Timothy Malouff retweeted
Thank you @QuadShotNews for highlighting our study! The modern effective neoadj targeted therapies for Her2+ BC trigger the curiousity to explore warranted adjuvant treatments. Our analysis hopefully gives some insight on this topic as we all eagerly wait for randomized data.
Timothy Malouff retweeted
#BlackHistoryMonth is a time to honor the past, celebrate the present & look to the future. This month we spotlight #cancer leaders, such as Dr. Jerry Jaboin. ow.ly/X7kB50MOzoi @drjcanJJ
Timothy Malouff retweeted
Evaluation of proton therapy reirradiation for patients with recurrent HNSCCC
Congratulations to @AnnaLeeMDMPH- PT in a previously irradiated area of the head and neck may live longer than photon-based reirradiation @MDAndersonNews @imrtlee @naptprotons bit.ly/3JZSMd0
